Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate
2017 · Molecular Therapy · 202 citations
https://doi.org/10.1016/j.ymthe.2016.10.019
M
Malcolm Boyce
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
137
Papers
3.3K
Citations
33
h-index
75
i10-index
Malcolm Boyce is an academic researcher from Hammersmith Medicines Research. The author has contributed to research in topics: Helicobacter pylori-related gastroenterology studies & Neuroendocrine Tumor Research Advances & Asthma and respiratory diseases. The author has an h-index of 33, co-authored 117 publications.
ORCID: 0000-0001-8807-612XPapers by this author
worksRandomized study of the safety and pharmacodynamics of inhaled interleukin-13 monoclonal antibody fragment VR942
2018 · EBioMedicine · 56 citations
https://doi.org/10.1016/j.ebiom.2018.07.035
A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients
2016 · Pulmonary Pharmacology & Therapeutics · 44 citations
https://doi.org/10.1016/j.pupt.2016.06.011
Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors
2020 · Cellular and Molecular Gastroenterology and Hepatology · 12 citations
https://doi.org/10.1016/j.jcmgh.2020.01.010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat